Analysts predict that eMagin Co. (NYSE:EMAN) will announce $6.30 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for eMagin’s earnings, with the lowest sales estimate coming in at $5.60 million and the highest estimate coming in at $7.70 million. eMagin reported sales of $4.31 million during the same quarter last year, which would suggest a positive year over year growth rate of 46.2%. The business is scheduled to report its next quarterly earnings report on Friday, November 10th.
According to Zacks, analysts expect that eMagin will report full year sales of $6.30 million for the current financial year, with estimates ranging from $22.70 million to $28.50 million. For the next fiscal year, analysts expect that the firm will post sales of $31.64 million per share, with estimates ranging from $28.00 million to $34.00 million. Zacks’ sales calculations are an average based on a survey of research firms that follow eMagin.
eMagin (NYSE:EMAN) last announced its earnings results on Thursday, August 10th. The semiconductor company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The company had revenue of $5.26 million for the quarter, compared to the consensus estimate of $6.00 million. eMagin had a negative return on equity of 44.28% and a negative net margin of 43.16%.
EMAN has been the subject of a number of research reports. Rodman & Renshaw reiterated a “buy” rating and set a $4.00 target price on shares of eMagin in a research report on Friday, June 23rd. HC Wainwright initiated coverage on shares of eMagin in a research report on Saturday, June 24th. They set a “buy” rating and a $4.00 target price for the company. Finally, Zacks Investment Research lowered shares of eMagin from a “hold” rating to a “sell” rating in a research report on Tuesday, August 15th.
A hedge fund recently bought a new stake in eMagin stock. Virtu KCG Holdings LLC acquired a new stake in eMagin Co. (NYSE:EMAN) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 42,044 shares of the semiconductor company’s stock, valued at approximately $103,000. Virtu KCG Holdings LLC owned 0.13% of eMagin at the end of the most recent quarter.
Shares of eMagin (NYSE EMAN) traded down 2.17% during mid-day trading on Friday, reaching $2.25. 20,518 shares of the company’s stock traded hands. eMagin has a 12-month low of $1.85 and a 12-month high of $3.00. The company’s market cap is $78.69 million. The firm has a 50-day moving average of $2.15 and a 200 day moving average of $2.37.
eMagin Company Profile
eMagin Corporation is engaged in the manufacture of microdisplays using organic light emitting diode (OLED) technology. The Company designs, develops, manufactures and markets OLED on silicon microdisplays, virtual imaging products that utilizes OLED microdisplays and related products. The Company also performs research in the OLED field.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for eMagin Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin Co. and related companies with our FREE daily email newsletter.